What should pharmaceutical companies do if a health professional/HCO donates their transfer of value to a third party, eg a charity, charitable trust or other institution?

  • 24.1

    24.1 Companies must document and publicly disclose certain transfers of value made directly or indirectly to health professionals and healthcare organisations located in Europe.

The purpose of disclosure is to bring greater transparency to the relationships between the pharmaceutical industry, healthcare professionals, other relevant decision makers and organisations. Companies are required to document and publicly disclose transfers of value made to health professionals and organisations (Clause 24.1). They should disclose, where lawfully able, those individuals or organisations to whom a transfer of value was made, regardless of what happens to that transfer of value afterwards. Recipients should be aware of the process.